Ferraccioli, Gianfranco
 Distribuzione geografica
Continente #
NA - Nord America 12.994
EU - Europa 8.175
AS - Asia 7.296
SA - Sud America 1.485
Continente sconosciuto - Info sul continente non disponibili 382
AF - Africa 232
OC - Oceania 33
AN - Antartide 1
Totale 30.598
Nazione #
US - Stati Uniti d'America 12.615
SG - Singapore 3.383
DE - Germania 2.021
CN - Cina 1.721
BR - Brasile 1.165
SE - Svezia 1.106
IT - Italia 1.094
FR - Francia 929
PL - Polonia 783
UA - Ucraina 683
VN - Vietnam 616
IE - Irlanda 384
GB - Regno Unito 371
IN - India 321
ID - Indonesia 262
FI - Finlandia 239
RU - Federazione Russa 197
CA - Canada 192
HK - Hong Kong 162
TR - Turchia 141
JP - Giappone 127
BD - Bangladesh 121
AR - Argentina 109
BE - Belgio 89
MX - Messico 82
IQ - Iraq 79
ZA - Sudafrica 68
VE - Venezuela 49
NL - Olanda 47
CO - Colombia 46
EC - Ecuador 42
IR - Iran 40
ES - Italia 39
PK - Pakistan 38
SA - Arabia Saudita 36
AU - Australia 27
CI - Costa d'Avorio 27
MA - Marocco 27
AT - Austria 26
KR - Corea 26
CL - Cile 23
PH - Filippine 23
JM - Giamaica 22
KE - Kenya 20
CH - Svizzera 19
JO - Giordania 19
CR - Costa Rica 17
UZ - Uzbekistan 17
CZ - Repubblica Ceca 16
EG - Egitto 16
IL - Israele 16
LT - Lituania 16
UY - Uruguay 16
RO - Romania 15
TN - Tunisia 15
HN - Honduras 14
NP - Nepal 14
AZ - Azerbaigian 13
DZ - Algeria 13
PE - Perù 13
AE - Emirati Arabi Uniti 12
BO - Bolivia 12
EU - Europa 12
DK - Danimarca 11
GR - Grecia 11
TT - Trinidad e Tobago 11
AL - Albania 10
KG - Kirghizistan 10
PY - Paraguay 10
MY - Malesia 9
NI - Nicaragua 9
PA - Panama 9
PT - Portogallo 9
A2 - ???statistics.table.value.countryCode.A2??? 8
BG - Bulgaria 8
ET - Etiopia 8
LB - Libano 8
LK - Sri Lanka 8
NO - Norvegia 8
OM - Oman 8
TH - Thailandia 8
SN - Senegal 7
TW - Taiwan 7
KH - Cambogia 6
LA - Repubblica Popolare Democratica del Laos 6
LV - Lettonia 6
NG - Nigeria 6
SV - El Salvador 6
AM - Armenia 5
HU - Ungheria 5
KZ - Kazakistan 5
NZ - Nuova Zelanda 5
AO - Angola 4
EE - Estonia 4
GE - Georgia 4
MM - Myanmar 4
SC - Seychelles 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
BA - Bosnia-Erzegovina 3
Totale 30.161
Città #
Singapore 1.752
Ashburn 1.388
Chandler 1.287
San Jose 971
Warsaw 630
Jacksonville 412
Ann Arbor 390
Dearborn 371
Dublin 366
San Mateo 319
Beijing 309
Wilmington 288
Fairfield 273
Nanjing 250
Woodbridge 238
Jakarta 234
New York 222
Los Angeles 215
Ho Chi Minh City 199
Lauterbourg 195
Houston 192
Seattle 183
Boston 180
Cattolica 178
Hanoi 169
Council Bluffs 167
Munich 154
Hong Kong 152
Dallas 144
Lawrence 140
Milan 124
Kraków 121
Chicago 113
Hefei 107
Moscow 106
Rome 106
São Paulo 104
Frankfurt am Main 102
The Dalles 101
Tokyo 98
Redwood City 92
Bremen 91
Marseille 86
Cambridge 84
Izmir 84
Santa Clara 84
Brussels 82
Nürnberg 81
Nanchang 76
Buffalo 69
Princeton 68
Boardman 63
Kunming 61
Orem 61
Atlanta 60
Helsinki 59
Lancaster 59
Norwalk 58
Pune 56
Mountain View 51
Phoenix 50
Montreal 49
London 48
Guangzhou 46
Hebei 46
Toronto 44
Shenyang 43
Brooklyn 39
Tianjin 39
Shanghai 38
University Park 37
Denver 36
Hangzhou 36
Paris 36
San Francisco 36
Redmond 35
Detroit 34
Baghdad 33
Da Nang 33
Falls Church 31
Johannesburg 30
Chennai 29
Jiaxing 27
Abidjan 26
Brasília 26
Changsha 26
Nuremberg 26
Rio de Janeiro 26
Stockholm 24
Zhengzhou 24
Fremont 23
Washington 23
Jinan 22
Naples 22
Philadelphia 22
Belo Horizonte 21
Dhaka 21
Kent 21
Leawood 21
Manchester 21
Totale 15.745
Nome #
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue 453
Modeling the ternary complex TCR-Vbeta/CollagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis. 448
The prognostic significance of the Birmingham Vasculitis Activity Score (BVAS) with systemic vasculitis patients transferred to the intensive care unit (ICU) 366
MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis 359
Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis 352
B CELL DEPLETION IN DIFFUSE PROGRESSIVE SYSTEMIC SCLEROSIS: SAFETY, SKIN SCORE MODIFICATION AND IL-6 MODULATION IN AN UP TO THIRTY-SIX MONTHS FOLLOW-UP OPEN-LABEL TRIAL 328
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis 319
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 305
Comprehensive review on intravertebral intraspinal, intrajoint, and intradiscal vacuum phenomenon: from anatomy and physiology to pathology 305
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 285
Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis 275
Troponin in Stable Ischemic Heart Disease and Diabetes 273
B cell subsets in the joint compartments of seropositive and seronegative RA and non-RA arthritides express memory markers and ZAP-70 and characterize the aggregate pattern irrespectively of the autoantibody status. 272
MicroRNA-155-at the Critical Interface of Innate and Adaptive Immunity in Arthritis. 271
Troponin in Stable Ischemic Heart Disease and Diabetes 263
Impatto dell’inquinamento ambientale da benzene e PM10 sulla progressione clinica della sclerosi sistemica: un’analisi di correlazione. 254
Chemerin and PEDF are metaflammation-related biomarkers of disease activity and obesity in rheumatoid arthritis 252
Synovial fluid-derived T helper 17 cells correlate with inflammatory activity in arthritis, irrespectively of diagnosis. 244
MR imaging of atlantoaxial joint in early rheumatoid arthritis. 240
The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis. 235
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment 234
beta-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up 230
Collagen-specific T cell repertoire in blood and synovial fluid varies with disease activity in Early Rheumatoid Arthritis. 226
Synovial tissue derived characteristics are included in a nomogram for the prediction of treatment response in naïve Rheumatoid Arthritis 217
Allocare risorse nel settore di farmaci biologici: il caso di Etanercept per il trattamento dell’artrite reumatoide 216
Atlantoepistrophic magnetic resonance imaging involvement in early rheumatoid arthritis: an aggressive tight control therapy not fully arresting the disease 214
B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and No-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status 213
Septic sacroiliitis: an uncommon septic arthritis 210
Haemophilus parasuis (Glaesserella parasuis) as a Potential Driver of Molecular Mimicry and Inflammation in Rheumatoid Arthritis 209
Proteomic approaches to Sjögren's syndrome: a clue to interpret the pathophysiology and organ involvement of the disease. 205
Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression 205
A vascular endothelial growth factor deficiency characterises scleroderma lung disease 205
MicroRNA-155 influences B-cell function through PU.1 in rheumatoid arthritis 204
Porphyromonas gingivalis and the pathogenesis of rheumatoid arthritis: analysis of various compartments including the synovial tissue. 202
An autosomal recessive DNASE1L3-related autoimmune disease with unusual clinical presentation mimicking systemic lupus erythematosus 202
Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein 197
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 197
Systemic Bone Density at Disease Onset Is Associated With Joint Erosion Progression in Early Naive to Treatment Rheumatoid Arthritis: A Prospective 12-Month Follow-Up Open-Label Study 192
Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis 191
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 191
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis 191
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections 187
Very early rheumatoid arthritis is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. 185
B CELLS IN SYSTEMIC SCLEROSIS: A POSSIBLE TARGET FOR THERAPY 184
The role of High-mobility group box protein 1 in collagen antibody-induced arthritis is dependent on Vascular endothelial growth factor. 182
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 181
ZAP-70+ B Cell Subset Influences Response to B Cell Depletion Therapy and Early Repopulation in Rheumatoid Arthritis 180
Proteome analysis of biological fluids from autoimmune-rheumatological disorders 178
Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis 175
Detection of bone erosions in early rheumatoid arthritis: 3D ultrasonography versus computed tomography 175
Tapering and discontinuation of TNF-α blockers without disease relapse using ultrasonography as a tool to identify patients with rheumatoid arthritis in clinical and histological remission 175
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 174
Quantitative and semi-quantitative computed tomography analysis of interstitial lung disease associated with systemic sclerosis: A longitudinal evaluation of pulmonary parenchyma and vessels 174
ENVIRONMENTAL POLLUTION AND SYSTEMIC SCLEROSIS: A PILOT STUDY ON BENZENE AND PARTICULATE EXPOSURE AS RISK FACTORS FOR THE SYSTEMIC MANIFESTATIONS 173
Memory B cell subsets and plasmablasts are lower in early than in long-standing rheumatoid arthritis 172
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 172
Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: A clue to interpret different chances of relapse after clinical remission? 167
Baseline shoulder ultrasonography is not a predictive marker of response to glucocorticoids in patients with polymyalgia rheumatica: A 12-month followup study 167
Body weight, gender and response to TNF-α blockers in axial spondyloarthritis 166
Selective Inhibitors of T Cell Receptor Recognition of Antigen–MHC Complexes for Rheumatoid Arthritis 164
Preliminary classification criteria for the cryoglobulinaemic vasculitis 160
Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease 159
Clinical and ultrasonographic remission determines different chances of relapse in early and long standing rheumatoid arthritis. 157
The potential role of Th17 in mediating the transition from acute to chronic autoimmune inflammation: rheumatoid arthritis as a model. 155
A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen. 154
Preserved cardiorespiratory function and NT-proBNP levels before and during exercise in patients with recent onset of rheumatoid arthritis: the clinical challenge of stratifying the patient cardiovascular risks 154
Characterization of inflammatory cell infiltrate of scleroderma skin: B cells and skin score progression. 153
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy 152
Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases) 152
Gut microbiota analysis in systemic sclerosis according to disease characteristics and nutritional status 151
PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis 150
New therapeutic effects of cilostazol in patients with ischemic disorders. 148
Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis 147
Environmental pollution and systemic sclerosis manifestations: a pilot study on benzene and particulate exposure 146
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 145
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 145
Prognostic Role of Ventricular Ectopic Beats in Systemic Sclerosis: A Prospective Cohort Study Shows ECG Indexes Predicting the Worse Outcome 144
Tumour-associated antigens in systemic sclerosis patients with interstitial lung disease: association with lung involvement and cancer risk 144
Thymosin β4 and β10 in Sjögren's syndrome: Saliva proteomics and minor salivary glands expression 142
Cilostazol improves the response to ischemia in diabetic mice by a mechanism dependent on PPARγ. 141
Is Citrullination Required for the Presence of Restricted Clonotypes Reacting With Type II Collagen? Comment on the Article by Chemin et al 141
Life-threatening arrhythmias in a scleroderma patient: the role of myocardial inflammation in arrhythmic outburst 139
Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study 137
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: A post hoc analysis of a phase III trial 137
Checkpoint inhibitors (CPI) and autoimmune chronic inflammatory diseases (ACIDs): tolerance and loss of tolerance in the occurrence of immuno-rheumatologic manifestations 136
The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk 135
Synovial predictors of differentiation to definite arthritis in patients with seronegative undifferentiated peripheral inflammatory arthritis: MicroRNA signature, histological, and ultrasound features 135
Biomolecular features of inflammation in obese rheumatoid arthritis patients: management considerations 133
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies 133
Immune-Guided Therapy of COVID-19 133
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response. 131
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered 131
Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study 130
Paradoxical arthritis occurring during anti-TNF in patients with Inflammatory Bowel Disease: histological and immunological features of a complex synovitis. 129
Prevalence and incidence of osteoporotic fractures in patients on long-term glucocorticoid treatment for rheumatic diseases: The glucocorticoid induced OsTeoporosis TOol (GIOTTO) study 129
Artrite reumatoide. Terapia 128
Peripheral blood CD4posCD25posFoxP3pos cells and inflammatory cytokines as biomarkers of response in rheumatoid arthritis patients treated with CTLA4-Ig 127
Polimialgia reumatica ed arterite temporale di Horton 126
Efficacy and safety of rituximab with and without methotrexate in the treatment of rheumatoid arthritis patients: results from the GISEA register 126
Biomarkers of Good EULAR Response to the B Cell Depletion Therapy in All Seropositive Rheumatoid Arthritis Patients: Clues for the Pathogenesis 124
Totale 19.420
Categoria #
all - tutte 127.551
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 127.551


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.524 0 0 0 102 131 75 69 296 92 141 272 346
2022/20233.649 461 485 283 597 262 434 151 323 416 45 115 77
2023/20241.773 85 543 67 76 50 243 125 94 18 52 270 150
2024/20253.291 73 93 294 118 323 87 75 165 526 293 633 611
2025/20268.740 1.516 288 485 871 1.513 467 1.622 390 518 609 254 207
2026/20272.703 478 1.152 569 504 0 0 0 0 0 0 0 0
Totale 30.598